Quick Answer
Actinium Pharmaceuticals, Inc. reported Cash And Cash Equivalents At Carrying Value of $48.00 million for the year ending 2025.
- Actinium Pharmaceuticals, Inc. showed a decrease of -34.2% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from Actinium Pharmaceuticals, Inc.'s annual report (Form 10-K), filed with the SEC on March 30, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), Actinium Pharmaceuticals, Inc.'s Cash And Cash Equivalents At Carrying Value has grown by 2,261,822.7%.
- Historical annual values: Fiscal year 2025: $48.00 million | Fiscal year 2024: $72.90 million | Fiscal year 2023: $76.68 million | Fiscal year 2022: $108.91 million | Fiscal year 2021: $77.83 million | Fiscal year 2020: $63.56 million | Fiscal year 2019: $9.25 million | Fiscal year 2018: $13.67 million | Fiscal year 2017: $17.40 million | Fiscal year 2016: $20.52 million | Fiscal year 2015: $25.64 million | Fiscal year 2014: $6.71 million | Fiscal year 2013: $5.53 million | Fiscal year 2012: $5.62 million | Fiscal year 2011: $5.70 million | Fiscal year 2010: $196.1 thousand | Fiscal year 2009: $2.1 thousand.
- Data sourced from SEC EDGAR public filings as of June 24, 2026.
Last verified: